review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Guillermo Armaiz-Pena | Q40252323 |
Anil K. Sood | Q88114757 | ||
P2093 | author name string | Susan K Lutgendorf | |
Steve W Cole | |||
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
Inflammation and cancer | Q24649640 | ||
Chronic stress and age-related increases in the proinflammatory cytokine IL-6 | Q24678400 | ||
Antihypertensive drug use and the risk of prostate cancer (Canada) | Q28209807 | ||
Distinct mechanism for antidepressant activity by blockade of central substance P receptors | Q28281932 | ||
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression | Q30304209 | ||
Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland | Q33755924 | ||
Towards a mechanistic understanding of tumor invasion--lessons from the alpha6beta 4 integrin | Q34231953 | ||
Epac proteins: multi-purpose cAMP targets | Q34579147 | ||
Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis | Q34615993 | ||
Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine | Q34947284 | ||
Stress hormone-mediated invasion of ovarian cancer cells | Q35120288 | ||
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms | Q35135129 | ||
Stress, depression, the immune system, and cancer | Q35909595 | ||
Chronic stress and susceptibility to skin cancer. | Q36174817 | ||
A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage | Q36471141 | ||
VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine | Q36485145 | ||
Neuroendocrine influences on cancer biology | Q36713229 | ||
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer | Q40059218 | ||
Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism | Q40089946 | ||
Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation | Q40160207 | ||
A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway | Q40177748 | ||
Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress | Q40202699 | ||
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells | Q40213140 | ||
Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells | Q40227360 | ||
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma | Q40252227 | ||
In Vitro Analysis of The Control of Keratinocyte Proliferation In Human Epidermis By Physiologic and Pharmacologic Agents | Q40333616 | ||
Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. | Q40626900 | ||
Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells | Q41729405 | ||
Stress-induced immune dysfunction: implications for health | Q43472077 | ||
Personality factors and breast cancer risk: a 13-year follow-up | Q43477732 | ||
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor | Q43592479 | ||
Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter | Q43654463 | ||
Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors | Q43836889 | ||
Neuro-endocrine cells--a new prognostic parameter in prostate cancer | Q43901060 | ||
Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells | Q44531462 | ||
The role of psychosocial factors in the development of breast carcinoma: Part I. The cancer prone personality. | Q51069068 | ||
The association between stressful life events and breast cancer risk: A meta‐analysis | Q52956585 | ||
Stressful Life Events and Risk of Breast Cancer in 10,808 Women: A Cohort Study | Q57257313 | ||
Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family | Q73274217 | ||
Vascular endothelial growth factor and social support in patients with ovarian carcinoma | Q74715935 | ||
Psychosocial factors and interleukin-6 among women with advanced ovarian cancer | Q81845545 | ||
P433 | issue | 1 | |
P304 | page(s) | 10-15 | |
P577 | publication date | 2008-06-27 | |
P1433 | published in | Brain, Behavior, and Immunity | Q15716593 |
P1476 | title | Neuroendocrine modulation of cancer progression | |
P478 | volume | 23 |
Q37646929 | A pilot study of blood epinephrine levels and CREB phosphorylation in men undergoing prostate biopsies |
Q89533988 | Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence |
Q33815723 | Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis |
Q35551991 | Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth. |
Q92891743 | Analysis of low-scattering regions in optical coherence tomography: applications to neurography and lymphangiography |
Q42316873 | Anticancer Molecules in Brain: Implication for Novel Strategy for Cancer Immunotherapy |
Q36580367 | Behavioral stress accelerates prostate cancer development in mice |
Q35949297 | Beta-adrenergic blocking drugs in breast cancer: a perspective review |
Q64965191 | Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression. |
Q90544208 | Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma |
Q35832813 | Caregiving burden, stress, and health effects among family caregivers of adult cancer patients |
Q36104836 | Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study |
Q35877948 | Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. |
Q58765646 | Circulating catecholamines are associated with biobehavioral factors and anxiety symptoms in head and neck cancer patients |
Q48689899 | Complementary medicine in cancer care: adding a therapy dog to the team. |
Q34679325 | Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis |
Q36418568 | Depression and Oropharynx Cancer Outcome |
Q39863552 | Environmental and Genetic Activation of Hypothalamic BDNF Modulates T-cell Immunity to Exert an Anticancer Phenotype. |
Q47235650 | Environmental stimuli shape microglial plasticity in glioma. |
Q37688989 | Gastrin-releasing peptide links stressor to cancer progression |
Q37386056 | Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer |
Q37720884 | Glucocorticoids induce production of reactive oxygen species/reactive nitrogen species and DNA damage through an iNOS mediated pathway in breast cancer |
Q33870764 | Hypothalamic gene transfer of BDNF inhibits breast cancer progression and metastasis in middle age obese mice |
Q37315173 | Impact of cardiovascular comorbidity on ovarian cancer mortality |
Q36776988 | Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy |
Q37708508 | Individual differences in pre-carcinogen cytokine and corticosterone concentrations and depressive-like behavior predict tumor onset in rats exposed to a carcinogen |
Q33936110 | Introduction to special series: The great debate--evaluating the health implications of positive psychology |
Q36900153 | Mindfulness-based interventions for physical conditions: a narrative review evaluating levels of evidence |
Q30431143 | Music-based interventions in palliative cancer care: a review of quantitative studies and neurobiological literature |
Q36306358 | Neuroendocrine influences on cancer progression. |
Q94414989 | Non–Registered Abstracts |
Q37471179 | Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer |
Q33905994 | Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer. |
Q34680318 | Psychosocially influenced cancer: diverse early-life stress experiences and links to breast cancer |
Q37762620 | Role of nervous system in cancer aetiopathogenesis |
Q39914415 | Role of the nervous system in cancer metastasis. |
Q91957848 | Something Else to Stress about: Perinatal Stress Attenuates CD8+ T Cell Activity in Adults |
Q50787852 | Sooner or later: age at onset of generalized anxiety disorder in older adults. |
Q36609338 | Stress management reduces intraindividual cortisol variability, while not impacting other measures of cortisol rhythm, in a group of women at risk for breast cancer |
Q38816004 | Stress management, leukocyte transcriptional changes and breast cancer recurrence in a randomized trial: An exploratory analysis. |
Q99572232 | Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies |
Q36535817 | Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer |
Q37389659 | The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure |
Q47703949 | The association between alcohol abuse and neuroendocrine system dysregulation: Race differences in a National sample |
Q37704694 | The influence of glucocorticoid signaling on tumor progression |
Q55346706 | The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis. |
Q41900633 | The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer |
Q39259364 | VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors |
Q38742275 | β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives. |
Search more.